Common tinea infections in children

American Family Physician

Volumn 77, Issue 10, 2008, Pages 1415-1420

  Andrews, Mark D ^a   Burns, Marianthe ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLAMINE DERIVATIVE; BUTENAFINE; CLOTRIMAZOLE; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; POTASSIUM HYDROXIDE; PYRROLE DERIVATIVE; SELENIUM SULFIDE; TERBINAFINE; ANTIFUNGAL AGENT;

ALOPECIA; ALOPECIA AREATA; ATOPIC DERMATITIS; CONTACT DERMATITIS; CUTANEOUS LUPUS ERYTHEMATOUS; DIFFERENTIAL DIAGNOSIS; DRUG ERUPTION; DYSHIDROSIS; ECZEMA; EPIDERMOPHYTON; ERYTHEMA MULTIFORME; ERYTHRASMA; FOMITE; FUNGUS CULTURE; GASTROINTESTINAL SYMPTOM; GRANULOMA ANNULARE; HISTOLOGY; HISTORY; HUMAN; IMPETIGO; INTERTRIGO; KERATOLYSIS; LICHEN PLANUS; LIVER TOXICITY; MICROSCOPY; MICROSPORUM; NAIL DYSTROPHY; NAUSEA; ONYCHOMYCOSIS; PEDICULOSIS; PHOTOSENSITIVITY; PHYSICAL EXAMINATION; PITYRIASIS; PITYRIASIS ROSEA; PSORIASIS; RECOMMENDED DRUG DOSE; REVIEW; SEBORRHEA; SEBORRHEIC DERMATITIS; SECONDARY SYPHILIS; SKIN DEFECT; SOIL POLLUTION; TINEA CAPITIS; TINEA CORPORIS; TINEA CRURIS; TINEA MANUUM; TINEA PEDIS; TINEA VERSICOLOR; TRICHOPHYTON; TRICHOTILLOMANIA; VOMITING; CHILD; CHILD WELFARE; DOSE RESPONSE; ISOLATION AND PURIFICATION; ORAL DRUG ADMINISTRATION; RISK FACTOR; TINEA; TOPICAL DRUG ADMINISTRATION; UNITED STATES;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANTIFUNGAL AGENTS; CHILD; CHILD WELFARE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; RISK FACTORS; TINEA; TINEA CAPITIS; TINEA PEDIS; TRICHOPHYTON; UNITED STATES;

EID: 45549100315     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Smith SD, Relman DA. Dermatophytes. In: Wilson WR, Sande MA. Current Diagnosis and Treatment in Infectious Diseases. New York, NY: McGraw-Hill Professional; 2001:777-778.
2. Hostetter MK. Fungal infections in normal children. In: Gershon AA, Hotez PJ, Katz SL, Krugman S, eds. Gershon: Krugman's Infectious Diseases of Children. 11th ed. St. Louis, Mo.: Mosby; 2004.
3. Noble, SL, Forbes, RC, Stamm PL. Diagnosis and management of common tinea infections. Am Fam Physician. 1998;58(1):163-174. (Pubitemid 28332430)
4. Karimzadegan-Nia M, Mir-Amin-Mohammadi A, Bouzari N, Firooz A. Comparison of direct smear, culture and histology for the diagnosis of onychomycosis. Australas J Dermatol. 2007;48(1):18-21. (Pubitemid 46046261)
5. Aly R. Ecology, epidemiology and diagnosis of tinea capitis. Pediatr Infect Dis J. 1999;18(2):180-185. (Pubitemid 29101901)
6. Hubbard TW. The predictive value of symptoms in diagnosing childhood tinea capitis. Arch Pediatr Adolesc Med. 1999;153(11):1150-1153. (Pubitemid 29521737)
7. Friedlander SF, Pickering B, Cunningham BB, Gibbs NF, Eichenfield LF. Use of the cotton swab method in diagnosing tinea capitis. Pediatrics. 1999;104(2 pt 1):276-279. (Pubitemid 29362136)
8. Bennett ML, Fleischer AB, Loveless JW, Feldman SR. Oral griseofulvin remains the treatment of choice for tinea capitis in children. Pediatr Dermatol. 2000;17(4):304-309. (Pubitemid 30679553)
9. Friedlander SF, Aly R, Krafchik B, et al. Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study. Pediatrics. 2002;109(4):602-607. (Pubitemid 34286292)
10. Ergin S, Ergin C, Erdogan BS, Kaleli I, Evliyaoglu D. An experience from an outbreak of tinea capitis gladiatorum due to Trichophyton tonsurans. Clin Exp Dermatol. 2006;31(2):212-214.
11. Fleece D, Gaughan JP, Aronoff SC. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials. Pediatrics. 2004;114(5):1312-1315. (Pubitemid 41647694)
12. Pickering LK. Tinea capitis. In: Pickering LK. Red Book: 2006 Report of the Committee on Infectious Diseases. Elk Grove Village, Ill.: American Academy of Pediatrics; 2006:654-656.
13. Cáceres-Ríos H, Rueda M, Ballona R, Bustamante B. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis. J Am Acad Dermatol. 2000;42(1 pt 1):80-84. (Pubitemid 30470324)
14. Lamisil (terbinafine). In: Physician's Desk Reference Red Book 2007. Oxford, U.K.: Blackwell; 2007:2232.
15. Allen HB, Honig PJ, Leyden JJ, McGinley KJ. Selenium sulfide: adjuncitve therapy for tinea capitis. Pediatrics. 1982;69(1):81-83. (Pubitemid 12209674)
16. Givens TG, Murray MM, Baker RC. Comparison of 1% and 2.5% selenium sulfide in the treatment of tinea capitis. Arch Pediatr Adolesc Med. 1995;149(7):808-811.
17. Hart R, Bell-Syer SE, Crawford F, Torgerson DJ, Young P, Russell I. Systematic review of topical treatments for fungal infections of the skin and nails of the feet. BMJ. 1999;319(7202):79-82. (Pubitemid 29313235)
18. Davis R, Balfour JA. Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections. Pharmacoeconomics. 1995;8(3):253-269.
19. Greenberg HL, Shwayder TA, Bieszk N, Fivenson DP. Clotrimazole/ betamethasone diproprionate: a review of costs and complications in the treatment of common cutaneous fungal infections. Pediatr Dermatol. 2002;19(1):78-81. (Pubitemid 34233573)
20. Adams BB. Tinea corporis gladiatorum: a cross-sectional study. J Am Acad Dermatol. 2000;43(6):1039-1041.
21. Habif TP. Superficial fungal infections. In: Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 4th ed. New York, NY: Mosby; 2004.
22. Lilly KK, Koshnick RL, Grill JP, Khalil ZM, Nelson DB, Warshaw EM. Cost-effectiveness of diagnostic tests for toenail onychomycosis: a repeated measure, single-blinded, cross-sectional evaluation of 7 diagnostic tests. J Am Acad Dermatol. 2006;55(4):620-626. (Pubitemid 44436640)
23. Weinberg JM, Koestenblatt EK, Tutrone WD, Tishler HR, Najarian L. Comparison of diagnostic methods in the evaluation of onychomycosis. J Am Acad Dermatol. 2003;49(2):193-197. (Pubitemid 36951263)
24. Crawford F, Young P, Godfrey C, et al. Oral treatments for toenail onychomycosis: a systematic review. Arch Dermatol. 2002;138(6):811-816. (Pubitemid 34625527)
25. Warshaw EM, Fett DD, Bloomfield HE, et al. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial. J Am Acad Dermatol. 2005;53(4):578-584. (Pubitemid 41399923)
26. Epstein E. How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data. Arch Dermatol. 1998;134(12):1551-1554. (Pubitemid 29009255)